Tonix Pharmaceuticals Walks Out From COVID-19 Antiviral Pact

TipRanks Are Ecommerce Stocks Ready for a Comeback? Analysts Offer 3 Beaten-Down Names With Big Upside Potential Economic headwinds, in the form of rising inflation, rising interest rates, a possible ...

Tonix Pharmaceuticals jumps 25%, and here is why

Tonix Pharmaceuticals Corp (NASDAQ: TNXP) was up 25% after announcing that the US Patent and Trademark Office gave it a US Patent No. 11,342,896 on May 31, 2022. The patent is titled “Synthetic Chimer...